EUVIMEDEUVIMED entdecken
Leserbrief

Beyond the Left Main Treatment Decision

Fatih Furkan Bedir iD, Aybüke Şimşek Bedir iD, Abdullah Doğan iD, Ahmet Güner iD

Catheterization and Cardiovascular Interventions · 05.11.2026

DOI: 10.1002/ccd.70973 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Catheterization and Cardiovascular Interventions, online erschienen am 05.11.2026. Verfasst von Fatih Furkan Bedir und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Türkiye. Die Arbeit nennt 1 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To the Editor, We read with great interest the study by Bröchner et al. evaluating outcomes after percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), or deferred revascularization in patients with isolated unprotected left main disease [1].The inclusion of a deferred cohort addresses an important clinical question; however, several methodological and analytical issues merit consideration.

Autor:innen und Institutionen

  • Department of Cardiology, Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Türkiye.

ORCID-Profile: Fatih Furkan Bedir, Aybüke Şimşek Bedir, Abdullah Doğan, Ahmet Güner

Zitieren

APA

Bedir, F. F., Bedir, A. Ş., Doğan, A., & Güner, A. (2026). Beyond the Left Main Treatment Decision. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70973

Vancouver

Bedir FF, Bedir AŞ, Doğan A, Güner A. Beyond the Left Main Treatment Decision. Catheterization and Cardiovascular Interventions. 2026. doi:10.1002/ccd.70973

BibTeX
@article{Bedir2026,
  author = {Bedir, Fatih Furkan and Bedir, Aybüke Şimşek and Doğan, Abdullah and Güner, Ahmet},
  title = {Beyond the Left Main Treatment Decision},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2026},
  doi = {10.1002/ccd.70973}
}
Kostenlos starten →